Clinical Trial Update: Deucravacitinib in the Treatment of Cicatricial Alopecias [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating deucravacitinib for cicatricial alopecias, including Central Centrifugal Cicatricial Alopecia and Fron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Centrifugal Cicatricial Alopecia
• Frontal Fibrosing Alopecia

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Central Centrifugal Cicatricial Alopecia, Frontal Fibrosing Alopecia | Phase 2 | Status: NOT_YET_RECRUITING